PER CURIAM.
Plaintiff Thomas W. Kenyon filed a September 3, 2014 complaint against defendants Rutgers University, Bruce Fehn, and Natalie Horowitz for violations of the Conscientious Employee Protection Act (CEPA), N.J.S.A. 34:19-1 to-14. Plaintiff claims he complained to his superiors about Rutgers' procurement methods, alleging that he reasonably believed Rutgers was subject to state procurement laws, and in the alternative, that he reasonably believed Rutgers' procurement methods violated public policy because they breached its fiduciary duty to taxpayers. Plaintiff claims Rutgers retaliated and subsequently terminated plaintiff's employment because he objected to Rutgers' procurement methods. On October 14, 2016, the court granted defendants' summary judgment motion and denied plaintiff's discovery motion, which sought to depose two additional witnesses and obtain an expert on state procurement law. Plaintiff appeals and we reverse and remand for the court to state its reasons for its decisions.
Defendants filed an initial motion for summary judgment on April 29, 2016. On June 10, 2016, the court entered a Case Management Order (CMO) extending the discovery end date to September 15, 2016, and postponing the trial date to October 31, 2016. Defendants renewed their motion for summary judgment on September 2, 2016, seeking to dismiss plaintiff's claim in its entirety.
On September 13, 2016, plaintiff filed a notice of motion to extend the discovery date for an additional sixty days to obtain a procurement expert and to depose two additional witnesses. The trial court subsequently entered orders granting defendants' summary judgment motion and denying plaintiff's motion to extend discovery. A handwritten note on the summary judgment order states that "a written opinion will be issued as soon as possible." The trial court stated on the record that a written opinion would follow explaining its findings and reasons for the summary judgment decision. The order denying further discovery indicated reasons were placed on the record, although they were not. No written opinion was issued with regard to either order.
Plaintiff began his employment with the University of Medicine and Dentistry of New Jersey (UMDNJ) in October 2006. He was appointed to the position of Vice President, Supply Chain Management on May 30, 2007. Plaintiff stated that in 2006 or 2007, a Federal Monitor assigned to oversee the UMDNJ procurement department restructuring told plaintiff that Rutgers was required to follow state procurement laws. Rutgers is actually exempt from the Public Contracts Law, N.J.S.A. 52:34-1 to-25.1
In or around June or July 2012, plaintiff became aware of the pending merger of UMDNJ into Rutgers. Defendant Bruce Fehn stated that Rutgers handled the assimilation related to the merger and that Rutgers' management made the ultimate decisions regarding the merger. Rutgers retained PricewaterhouseCoopers (PwC) to serve as a consultant and facilitate pre-merger meetings. Rutgers' procurement policies and systems were determined to be the controlling policies and applicable operating systems in the post-merger institution.
After the merger was announced, pre-merger meetings were held twice a week between plaintiff, PwC consultants, which included Christina Sherma, and the then-Director of Purchasing for Rutgers, defendant Natalie Horowitz. It was at these meetings that plaintiff states he expressed his concerns to Horowitz about Rutgers' procurement policies and objected to Rutgers' lack of advertised bidding and centralized procurement. Plaintiff claims that after he voiced these concerns, he was no longer invited to these pre-merger meetings beginning in February or March 2013. When plaintiff asked why he was not being included in the meetings, Horowitz stated that he was "so far advanced" and the group was meeting to focus on Rutgers. Plaintiff was not yet a Rutgers employee at the time. He did not tell Horowitz that he believed Rutgers' procurement process was illegal or unlawful, but plaintiff says he told Horowitz he believed the lack of centralization in procurement led to misappropriation of taxpayers' funds.
On July 1, 2013, the majority of UMDNJ merged into Rutgers pursuant to the New Jersey Medical and Health Sciences Education Restructuring Act, N.J.S.A. 18A:64M-1 to-43. As a result, the UMDNJ and Rutgers' procurement departments merged, leaving only one position available for Executive Director of Procurement for Rutgers. Fehn, as Rutgers' Senior Vice President of Administration, chose Horowitz to be the Executive Director for Procurement, because of Horowitz's familiarity with Rutgers' systems.
As a result of the merger, plaintiff became a Rutgers employee: the Associate Director of Strategic Sourcing in the procurement department. Plaintiff reported directly to Horowitz and was responsible for twelve employees. Plaintiff's new position paid $112,000, significantly less than his $190,000 salary at UMDNJ. After becoming a Rutgers employee, Horowitz expressed concern to plaintiff about his job performance.
On October 4, 2013, plaintiff took a medical leave of absence. Rutgers approved plaintiff's medical leave request through January 3, 2014, but notified plaintiff that pursuant to Rutgers' policy, a medical leave could not exceed six months within a rolling twelve-month period. Plaintiff requested extensions on his medical leave, which were granted through April 4, 2014. After being advised that no additional leave was available, he did not return to work and submitted a "Certification of Health Care Provider" advising that the probable duration of incapacity was one year. Rutgers denied the additional leave time and subsequently terminated plaintiff on April 21, 2014. Plaintiff stated that the reason for his medical leave was due to the toxic work environment created by Horowitz and Fehn, causing plaintiff to suffer anxiety, high blood pressure and severe headaches.
CEPA is a "remedial legislation entitled to liberal construction, its public policy purpose to protect whistleblowers from retaliation by employers having been long recognized by the courts of this State."
To establish a prima facie case for a cause of action under CEPA, a plaintiff must show:
"A plaintiff who brings a claim pursuant to N.J.S.A. 34:19-3(c) need not show that his or her employer or another employee actually violated the law or a clear mandate of public policy."
"[W]hen a plaintiff brings an action pursuant to N.J.S.A. 34:19-3(c), the trial court must identify a statute, regulation, rule, or public policy that closely relates to the complained-of conduct."
The elements of a CEPA claim that a plaintiff must prove differ slightly between N.J.S.A. 34:19-3(c)(1) and (3):
But "a plaintiff who pursues a CEPA claim under [N.J.S.A. 34:19-3(c)(3)] may rely upon the same laws, rules and regulations that may be the subject of a claim under [N.J.S.A. 34:19-3(c)(1)]."
Once a plaintiff establishes a prima facie CEPA claim, a defendant must then "come forward and advance a legitimate, nondiscriminatory reason for making the adverse decision."
The trial court must provide reasons with its decisions, either on the record or written. As we said more than twenty years ago,
"Moreover, the appellate court ordinarily cannot perform its review function in the absence of findings."
Reversed and remanded. We do not retain jurisdiction.